As of 2024-07-27, the Relative Valuation of Fate Therapeutics Inc (FATE) is (48.63) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.44 USD, the upside of Fate Therapeutics Inc based on Relative Valuation is -993.9%.
The range of the Relative Valuation is (51.43) - (50.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 31.8x | 31.3x |
| Forward P/E multiples | 23.8x - 30.1x | 27.0x |
| Fair Price | (51.43) - (50.26) | (48.63) |
| Upside | -1045.3% - -1023.8% | -993.9% |
| Date | P/E |
| 2024-07-26 | -3.26 |
| 2024-07-25 | -3.23 |
| 2024-07-24 | -3.10 |
| 2024-07-23 | -3.34 |
| 2024-07-22 | -2.73 |
| 2024-07-19 | -2.56 |
| 2024-07-18 | -2.58 |
| 2024-07-17 | -2.67 |
| 2024-07-16 | -2.73 |
| 2024-07-15 | -2.33 |
| 2024-07-12 | -2.16 |
| 2024-07-11 | -2.04 |
| 2024-07-10 | -1.87 |
| 2024-07-09 | -1.87 |
| 2024-07-08 | -1.87 |
| 2024-07-05 | -1.90 |
| 2024-07-03 | -1.89 |
| 2024-07-02 | -1.93 |
| 2024-07-01 | -1.95 |
| 2024-06-28 | -1.96 |
| 2024-06-27 | -1.96 |
| 2024-06-26 | -1.95 |
| 2024-06-25 | -2.23 |
| 2024-06-24 | -2.30 |
| 2024-06-21 | -2.25 |
| 2024-06-20 | -2.15 |
| 2024-06-18 | -2.04 |
| 2024-06-17 | -2.14 |
| 2024-06-14 | -2.16 |
| 2024-06-13 | -2.25 |
| 2024-06-12 | -2.26 |
| 2024-06-11 | -2.33 |
| 2024-06-10 | -2.31 |
| 2024-06-07 | -2.20 |
| 2024-06-06 | -2.28 |
| 2024-06-05 | -2.25 |
| 2024-06-04 | -2.19 |
| 2024-06-03 | -2.20 |
| 2024-05-31 | -2.20 |
| 2024-05-30 | -2.07 |
| 2024-05-29 | -2.05 |
| 2024-05-28 | -2.12 |
| 2024-05-24 | -2.11 |
| 2024-05-23 | -2.05 |
| 2024-05-22 | -2.19 |
| 2024-05-21 | -2.22 |
| 2024-05-20 | -2.34 |
| 2024-05-17 | -2.34 |
| 2024-05-16 | -2.48 |
| 2024-05-15 | -2.54 |